title: The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
abstract: The adenosine A(2B) receptor is of considerable interest as a new drug target for the treatment of asthma, inflammatory diseases, pain, and cancer. In the present study we investigated the role of the cysteine residues in the extracellular loop 2 (ECL2) of the receptor, which is particularly cysteine-rich, by a combination of mutagenesis, molecular modeling, chemical and pharmacological experiments. Pretreatment of CHO cells recombinantly expressing the human A(2B) receptor with dithiothreitol led to a 74-fold increase in the EC(50) value of the agonist NECA in cyclic AMP accumulation. In the C78(3.25)S and the C171(45.50)S mutant high-affinity binding of the A(2B) antagonist radioligand [(3)H]PSB-603 was abolished and agonists were virtually inactive in cAMP assays. This indicates that the C3.25-C45.50 disulfide bond, which is highly conserved in GPCRs, is also important for binding and function of A(2B) receptors. In contrast, the C166(45.45)S and the C167(45.46)S mutant as well as the C166(45.45)S-C167(45.46)S double mutant behaved like the wild-type receptor, while in the C154(45.33)S mutant significant, although more subtle effects on cAMP accumulation were observed - decrease (BAY60-6583) or increase (NECA) - depending on the structure of the investigated agonist. In contrast to the X-ray structure of the closely related A(2A) receptor, which showed four disulfide bonds, the present data indicate that in the A(2B) receptor only the C3.25-C45.50 disulfide bond is essential for ligand binding and receptor activation. Thus, the cysteine residues in the ECL2 of the A(2B) receptor not involved in stabilization of the receptor structure may have other functions.
authors.affiliation: PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany. schiedel@uni-bonn.de
authors.forename: Anke C
authors.initials: AC
authors.lastname: Schiedel
authors.forename: Sonja
authors.initials: S
authors.lastname: Hinz
authors.forename: Dominik
authors.initials: D
authors.lastname: Thimm
authors.forename: Farag
authors.initials: F
authors.lastname: Sherbiny
authors.forename: Thomas
authors.initials: T
authors.lastname: Borrmann
authors.forename: Astrid
authors.initials: A
authors.lastname: Maass
authors.forename: Christa E
authors.initials: CE
authors.lastname: Müller
mesh_terms: D058917:Adenosine A2 Receptor Antagonists / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D016466:CHO Cells; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D018360:Crystallography, X-Ray; D003545:Cysteine / Q000737:chemistry* / Q000235:genetics / Q000502:physiology*; D004220:Disulfides / Q000737:chemistry; D045604:Extracellular Fluid / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D011485:Protein Binding / Q000235:genetics; D055550:Protein Stability; D017433:Protein Structure, Secondary; D043704:Receptor, Adenosine A2B / Q000737:chemistry* / Q000235:genetics / Q000502:physiology*
chemical_list: D058917:Adenosine A2 Receptor Antagonists; D004220:Disulfides; D008024:Ligands; D043704:Receptor, Adenosine A2B; D003545:Cysteine